IBDEI03C ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4048,2)
 ;;=^11387
 ;;^UTILITY(U,$J,358.3,4049,0)
 ;;=414.00^^24^234^3
 ;;^UTILITY(U,$J,358.3,4049,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4049,1,1,0)
 ;;=1^414.00
 ;;^UTILITY(U,$J,358.3,4049,1,2,0)
 ;;=2^CAD
 ;;^UTILITY(U,$J,358.3,4049,2)
 ;;=^28512
 ;;^UTILITY(U,$J,358.3,4050,0)
 ;;=425.4^^24^234^4
 ;;^UTILITY(U,$J,358.3,4050,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4050,1,1,0)
 ;;=1^425.4
 ;;^UTILITY(U,$J,358.3,4050,1,2,0)
 ;;=2^CARDIOMYOPATHY
 ;;^UTILITY(U,$J,358.3,4050,2)
 ;;=^87808
 ;;^UTILITY(U,$J,358.3,4051,0)
 ;;=V65.49^^24^234^5
 ;;^UTILITY(U,$J,358.3,4051,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4051,1,1,0)
 ;;=1^V65.49
 ;;^UTILITY(U,$J,358.3,4051,1,2,0)
 ;;=2^COUNSELING
 ;;^UTILITY(U,$J,358.3,4051,2)
 ;;=^303471
 ;;^UTILITY(U,$J,358.3,4052,0)
 ;;=V43.3^^24^234^6
 ;;^UTILITY(U,$J,358.3,4052,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4052,1,1,0)
 ;;=1^V43.3
 ;;^UTILITY(U,$J,358.3,4052,1,2,0)
 ;;=2^HEART VALVE REPLACEMENT
 ;;^UTILITY(U,$J,358.3,4052,2)
 ;;=^295440
 ;;^UTILITY(U,$J,358.3,4053,0)
 ;;=V67.51^^24^234^7
 ;;^UTILITY(U,$J,358.3,4053,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4053,1,1,0)
 ;;=1^V67.51
 ;;^UTILITY(U,$J,358.3,4053,1,2,0)
 ;;=2^HI-RISK RX F-U EXAM, NEC
 ;;^UTILITY(U,$J,358.3,4053,2)
 ;;=^295577
 ;;^UTILITY(U,$J,358.3,4054,0)
 ;;=V12.59^^24^234^8
 ;;^UTILITY(U,$J,358.3,4054,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4054,1,1,0)
 ;;=1^V12.59
 ;;^UTILITY(U,$J,358.3,4054,1,2,0)
 ;;=2^HX OF CIRCULATORY DISEASE
 ;;^UTILITY(U,$J,358.3,4054,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,4055,0)
 ;;=V12.51^^24^234^9
 ;;^UTILITY(U,$J,358.3,4055,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4055,1,1,0)
 ;;=1^V12.51
 ;;^UTILITY(U,$J,358.3,4055,1,2,0)
 ;;=2^HX OF THROMBOSIS/EMBOLISM
 ;;^UTILITY(U,$J,358.3,4055,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,4056,0)
 ;;=272.4^^24^234^11
 ;;^UTILITY(U,$J,358.3,4056,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4056,1,1,0)
 ;;=1^272.4
 ;;^UTILITY(U,$J,358.3,4056,1,2,0)
 ;;=2^HYPERLIPIDEMIA NOS
 ;;^UTILITY(U,$J,358.3,4056,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,4057,0)
 ;;=401.9^^24^234^12
 ;;^UTILITY(U,$J,358.3,4057,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4057,1,1,0)
 ;;=1^401.9
 ;;^UTILITY(U,$J,358.3,4057,1,2,0)
 ;;=2^HYPERTENSION NOS
 ;;^UTILITY(U,$J,358.3,4057,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,4058,0)
 ;;=V68.1^^24^234^13
 ;;^UTILITY(U,$J,358.3,4058,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4058,1,1,0)
 ;;=1^V68.1
 ;;^UTILITY(U,$J,358.3,4058,1,2,0)
 ;;=2^ISSUE REPEAT RX
 ;;^UTILITY(U,$J,358.3,4058,2)
 ;;=^295585
 ;;^UTILITY(U,$J,358.3,4059,0)
 ;;=V12.55^^24^234^10
 ;;^UTILITY(U,$J,358.3,4059,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4059,1,1,0)
 ;;=1^V12.55
 ;;^UTILITY(U,$J,358.3,4059,1,2,0)
 ;;=2^HX OF PULMONARY EMBOLISM
 ;;^UTILITY(U,$J,358.3,4059,2)
 ;;=^340615
 ;;^UTILITY(U,$J,358.3,4060,0)
 ;;=V58.83^^25^235^1
 ;;^UTILITY(U,$J,358.3,4060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4060,1,3,0)
 ;;=3^THERAPEUTIC DRUG MONITORING
 ;;^UTILITY(U,$J,358.3,4060,1,4,0)
 ;;=4^V58.83
 ;;^UTILITY(U,$J,358.3,4060,2)
 ;;=^322076
 ;;^UTILITY(U,$J,358.3,4061,0)
 ;;=99605^^26^236^1^^^^1
 ;;^UTILITY(U,$J,358.3,4061,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4061,1,2,0)
 ;;=2^MTMS BY PHARM,INIT 15 MIN
 ;;^UTILITY(U,$J,358.3,4061,1,3,0)
 ;;=3^99605
 ;;^UTILITY(U,$J,358.3,4062,0)
 ;;=99607^^26^236^2^^^^1
 ;;^UTILITY(U,$J,358.3,4062,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4062,1,2,0)
 ;;=2^MTMS BY PHARM, EA ADDL 15 MIN
 ;;^UTILITY(U,$J,358.3,4062,1,3,0)
 ;;=3^99607
 ;;^UTILITY(U,$J,358.3,4063,0)
 ;;=99606^^26^237^1^^^^1
 ;;^UTILITY(U,$J,358.3,4063,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4063,1,2,0)
 ;;=2^MTMS BY PHARM,INIT 15 MIN
 ;;^UTILITY(U,$J,358.3,4063,1,3,0)
 ;;=3^99606
 ;;^UTILITY(U,$J,358.3,4064,0)
 ;;=99607^^26^237^2^^^^1
 ;;^UTILITY(U,$J,358.3,4064,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4064,1,2,0)
 ;;=2^MTMS BY PHARM, EA ADDL 15 MIN
 ;;^UTILITY(U,$J,358.3,4064,1,3,0)
 ;;=3^99607
 ;;^UTILITY(U,$J,358.3,4065,0)
 ;;=98960^^26^238^1^^^^1
 ;;^UTILITY(U,$J,358.3,4065,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4065,1,2,0)
 ;;=2^INDIVIDUAL PATIENT, EA 30 MIN
 ;;^UTILITY(U,$J,358.3,4065,1,3,0)
 ;;=3^98960
 ;;^UTILITY(U,$J,358.3,4066,0)
 ;;=98961^^26^238^2^^^^1
 ;;^UTILITY(U,$J,358.3,4066,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4066,1,2,0)
 ;;=2^2-4 PATIENTS, EA 30 MIN
 ;;^UTILITY(U,$J,358.3,4066,1,3,0)
 ;;=3^98961
 ;;^UTILITY(U,$J,358.3,4067,0)
 ;;=98962^^26^238^3^^^^1
 ;;^UTILITY(U,$J,358.3,4067,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4067,1,2,0)
 ;;=2^5-8 PATIENTS, EA 30 MIN
 ;;^UTILITY(U,$J,358.3,4067,1,3,0)
 ;;=3^98962
 ;;^UTILITY(U,$J,358.3,4068,0)
 ;;=99221^^27^239^1
 ;;^UTILITY(U,$J,358.3,4068,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4068,1,1,0)
 ;;=1^DETAILED
 ;;^UTILITY(U,$J,358.3,4068,1,2,0)
 ;;=2^99221
 ;;^UTILITY(U,$J,358.3,4069,0)
 ;;=99222^^27^239^2
 ;;^UTILITY(U,$J,358.3,4069,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4069,1,1,0)
 ;;=1^MOD COMPREHENSIVE
 ;;^UTILITY(U,$J,358.3,4069,1,2,0)
 ;;=2^99222
 ;;^UTILITY(U,$J,358.3,4070,0)
 ;;=99223^^27^239^3
 ;;^UTILITY(U,$J,358.3,4070,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4070,1,1,0)
 ;;=1^HI COMPREHENSIVE
 ;;^UTILITY(U,$J,358.3,4070,1,2,0)
 ;;=2^99223
 ;;^UTILITY(U,$J,358.3,4071,0)
 ;;=99251^^27^240^1
 ;;^UTILITY(U,$J,358.3,4071,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4071,1,1,0)
 ;;=1^PROBLEM FOCUSED
 ;;^UTILITY(U,$J,358.3,4071,1,2,0)
 ;;=2^99251
 ;;^UTILITY(U,$J,358.3,4072,0)
 ;;=99252^^27^240^2
 ;;^UTILITY(U,$J,358.3,4072,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4072,1,1,0)
 ;;=1^EXP PROBLEM FOCUSED
 ;;^UTILITY(U,$J,358.3,4072,1,2,0)
 ;;=2^99252
 ;;^UTILITY(U,$J,358.3,4073,0)
 ;;=99253^^27^240^3
 ;;^UTILITY(U,$J,358.3,4073,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4073,1,1,0)
 ;;=1^DETAILED
 ;;^UTILITY(U,$J,358.3,4073,1,2,0)
 ;;=2^99253
 ;;^UTILITY(U,$J,358.3,4074,0)
 ;;=99254^^27^240^4
 ;;^UTILITY(U,$J,358.3,4074,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4074,1,1,0)
 ;;=1^MOD COMPREHENSIVE
 ;;^UTILITY(U,$J,358.3,4074,1,2,0)
 ;;=2^99254
 ;;^UTILITY(U,$J,358.3,4075,0)
 ;;=99255^^27^240^5
 ;;^UTILITY(U,$J,358.3,4075,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4075,1,1,0)
 ;;=1^HI COMPREHENSIVE
 ;;^UTILITY(U,$J,358.3,4075,1,2,0)
 ;;=2^99255
 ;;^UTILITY(U,$J,358.3,4076,0)
 ;;=99231^^27^241^1
 ;;^UTILITY(U,$J,358.3,4076,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4076,1,1,0)
 ;;=1^PROBLEM FOCUSED
 ;;^UTILITY(U,$J,358.3,4076,1,2,0)
 ;;=2^99231
 ;;^UTILITY(U,$J,358.3,4077,0)
 ;;=99232^^27^241^2
 ;;^UTILITY(U,$J,358.3,4077,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4077,1,1,0)
 ;;=1^EXP PROBLEM FOCUSED
 ;;^UTILITY(U,$J,358.3,4077,1,2,0)
 ;;=2^99232
 ;;^UTILITY(U,$J,358.3,4078,0)
 ;;=99233^^27^241^3
 ;;^UTILITY(U,$J,358.3,4078,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4078,1,1,0)
 ;;=1^DETAILED
 ;;^UTILITY(U,$J,358.3,4078,1,2,0)
 ;;=2^99233
 ;;^UTILITY(U,$J,358.3,4079,0)
 ;;=99238^^27^242^1
 ;;^UTILITY(U,$J,358.3,4079,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4079,1,1,0)
 ;;=1^D/C DAY MGMT < 30MIN
 ;;^UTILITY(U,$J,358.3,4079,1,2,0)
 ;;=2^99238
 ;;^UTILITY(U,$J,358.3,4080,0)
 ;;=99239^^27^242^2
 ;;^UTILITY(U,$J,358.3,4080,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4080,1,1,0)
 ;;=1^D/C DAY MGMT > 30MIN
 ;;^UTILITY(U,$J,358.3,4080,1,2,0)
 ;;=2^99239
 ;;^UTILITY(U,$J,358.3,4081,0)
 ;;=99218^^27^243^1
 ;;^UTILITY(U,$J,358.3,4081,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4081,1,1,0)
 ;;=1^DETAILED
 ;;^UTILITY(U,$J,358.3,4081,1,2,0)
 ;;=2^99218
 ;;^UTILITY(U,$J,358.3,4082,0)
 ;;=99219^^27^243^2
 ;;^UTILITY(U,$J,358.3,4082,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4082,1,1,0)
 ;;=1^MOD COMPREHENSIVE
 ;;^UTILITY(U,$J,358.3,4082,1,2,0)
 ;;=2^99219
 ;;^UTILITY(U,$J,358.3,4083,0)
 ;;=99220^^27^243^3
 ;;^UTILITY(U,$J,358.3,4083,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4083,1,1,0)
 ;;=1^HI COMPREHENSIVE
 ;;^UTILITY(U,$J,358.3,4083,1,2,0)
 ;;=2^99220
 ;;^UTILITY(U,$J,358.3,4084,0)
 ;;=99217^^27^244^1
 ;;^UTILITY(U,$J,358.3,4084,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4084,1,1,0)
 ;;=1^OBSERVATION D/C DAY
 ;;^UTILITY(U,$J,358.3,4084,1,2,0)
 ;;=2^99217
 ;;^UTILITY(U,$J,358.3,4085,0)
 ;;=99224^^27^245^1
 ;;^UTILITY(U,$J,358.3,4085,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4085,1,1,0)
 ;;=1^PROBLEM FOCUSED
 ;;^UTILITY(U,$J,358.3,4085,1,2,0)
 ;;=2^99224
 ;;^UTILITY(U,$J,358.3,4086,0)
 ;;=99225^^27^245^2
 ;;^UTILITY(U,$J,358.3,4086,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4086,1,1,0)
 ;;=1^EXP PROBLEM FOCUSED
 ;;^UTILITY(U,$J,358.3,4086,1,2,0)
 ;;=2^99225
 ;;^UTILITY(U,$J,358.3,4087,0)
 ;;=99226^^27^245^3
 ;;^UTILITY(U,$J,358.3,4087,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4087,1,1,0)
 ;;=1^DETAILED
 ;;^UTILITY(U,$J,358.3,4087,1,2,0)
 ;;=2^99226
 ;;^UTILITY(U,$J,358.3,4088,0)
 ;;=414.01^^28^246^21
 ;;^UTILITY(U,$J,358.3,4088,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4088,1,4,0)
 ;;=4^414.01
 ;;^UTILITY(U,$J,358.3,4088,1,5,0)
 ;;=5^CAD,Native Coronary
 ;;^UTILITY(U,$J,358.3,4088,2)
 ;;=CAD, Native Vessel^303281
 ;;^UTILITY(U,$J,358.3,4089,0)
 ;;=413.9^^28^246^6
 ;;^UTILITY(U,$J,358.3,4089,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4089,1,4,0)
 ;;=4^413.9
 ;;^UTILITY(U,$J,358.3,4089,1,5,0)
 ;;=5^Angina Pectoris
 ;;^UTILITY(U,$J,358.3,4089,2)
 ;;=Angina Pectoris^87258
 ;;^UTILITY(U,$J,358.3,4090,0)
 ;;=413.0^^28^246^7
 ;;^UTILITY(U,$J,358.3,4090,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4090,1,4,0)
 ;;=4^413.0
 ;;^UTILITY(U,$J,358.3,4090,1,5,0)
 ;;=5^Angina at Rest
 ;;^UTILITY(U,$J,358.3,4090,2)
 ;;=Angina at Rest^265313
 ;;^UTILITY(U,$J,358.3,4091,0)
 ;;=411.1^^28^246^9
 ;;^UTILITY(U,$J,358.3,4091,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4091,1,4,0)
 ;;=4^411.1
 ;;^UTILITY(U,$J,358.3,4091,1,5,0)
 ;;=5^Angina, Unstable
 ;;^UTILITY(U,$J,358.3,4091,2)
 ;;=Angina, Unstable^7455
